SCHEMBL19081485

SCHEMBL19081485

c1ccc(-c2ccc3cc(-c4c5ccccc5c(-c5c6oc7cc8ccccc8cc7c6cc6oc7ccccc7c56)c5ccccc45)ccc3c2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 1/20 0.34
PLA2G2A P14555 2/20 0.33
PLA2G4A P47712 2/20 0.33
HCRTR1 O43613 1/20 0.33
ESR1 P03372 3/20 0.32
ESR2 Q92731 3/20 0.32
AHR P35869 2/20 0.32
CYP1A2 P05177 2/20 0.32
CYP1A1 P04798 2/20 0.32
FYN P06241 1/20 0.32
MAPK3 P27361 1/20 0.32
PAX8 Q06710 1/20 0.32
ABCG2 Q9UNQ0 1/20 0.32
L3MBTL1 Q9Y468 3/20 0.32
TDP1 Q9NUW8 2/20 0.32
KDM4E B2RXH2 3/20 0.31
MAPT P10636 3/20 0.31
HPGD P15428 3/20 0.31
HSD17B10 Q99714 3/20 0.31
CASP3 P42574 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17945137 0.93 PGR (0.37) PGRPLA2G2APLA2G4AHCRTR1ESR1
SCHEMBL19081434 0.92 ESR1 (0.38) ESR1ESR2AHRCYP1A2CYP1A1
SCHEMBL19081596 0.90 NPC1 (0.33) PLA2G2APLA2G4AHCRTR1ESR1ESR2
SCHEMBL19081582 0.90 NPC1 (0.34) HCRTR1ESR1ESR2AHRCYP1A2
SCHEMBL17932118 0.88 HSD17B1 (0.35) PLA2G2APLA2G4AHCRTR1ESR1ESR2
SCHEMBL19081492 0.88 PGR (0.37) PGRPLA2G2APLA2G4AHCRTR1ESR1
SCHEMBL17932100 0.88 ESR1 (0.36) PGRPLA2G2APLA2G4AHCRTR1ESR1
SCHEMBL17944472 0.88 CYP1A1 (0.36) HCRTR1ESR2AHRCYP1A2CYP1A1
SCHEMBL17944837 0.86 AHR (0.36) PGRPLA2G2APLA2G4AESR1ESR2
SCHEMBL19081666 0.84 ALOX5 (0.34) ESR1AHRCYP1A2CYP1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 PGR 1721/4885PLA2G2A 4330/4885PLA2G4A 4338/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 PGR 1721/4885PLA2G2A 4330/4885PLA2G4A 4338/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.